The breadth of research happening at BC Cancer – Victoria is extensive, including basic science research, clinical and outcomes research, and clinical trials for cancer therapy. This body of work is possible through the work of our dedicated team, made up of clinical and research staff, and nationally and internationally recognized physician scientists.
The Clinical Trials and Clinical Research Program at BC Cancer – Victoria is one of our centre’s key priorities. Taking part in a clinical trial is voluntary and patients may be approached to participate in clinical trials and research in order to advance our knowledge in these areas, and to provide access to the latest therapies under investigation.
Open trials are trials that are currently accepting participants and can be searched by regional BC Cancer centre, by indication (tumour site), trial phase, or by drug/treatment.
Go to the BC Cancer Research Centre Clinical Trials page and use the search function to find the clinical trial you are interested in learning more about. For more information about a particular trial, please talk with your treating physician first, who may contact the regional centre if necessary.
Head and Neck Application for Patients and their Partners
(HANC APP) Study
Video: Information Needs of Patients with Head & Neck Cancer & Their Supports: A Scoping Review (Youtube.com)
|
Head & Neck
| Dr. Jonathan
Livergant
|
2023
|
Personas to Support Health Care Provider Use of Electronic Patient-Reported Outcomes in the Care of Older Adults with Cancer
| All
| Dr. Jae-Yung Kwon
|
November 2021
|
Locoregional radiotherapy in breast cancer patients treated with neoadjuvant chemotherapy
| Breast
| Dr. Pauline Truong
|
July 2020
|
Inflammatory Breast
Cancer: A Population
Based Study of Patients
Treated in BC in the
Modern Era
| Breast
| Dr. Maryam Dosani
|
IN SET-UP
|
Gynae PET: Evaluation of Post-Treatment PET Scans
for Gynecologic Cancers
| Cervical
| Dr. Caroline Holloway
| March 2021
|
Quantitative 18F-FDG Positron Emission Tomography / Computed Tomography (PET/CT) in the Assessment of Cervical Cancer
| Cervical
| Dr. Caroline Holloway
| November 2021
|
Gynae Path Review:
Evaluation of Post-Treatment PET Scans for Gynecologic Cancers
| Endometrial
| Dr. Caroline Holloway
| July 2021
|
HN B-COMP: Assessment of body composition and microbiome during active treatment in head and neck cancer
| Head/Neck
| Dr. Julianna Caon
| IN SET-UP
|
G-Tube IDA: Pre-treatment G-tube insertion decision aid for head and neck squamous cell carcinoma patients
|
Head/Neck
| Eleah Stringer
| IN SET-UP
|
Utility of electronic decision-support tools for patients with head and neck cancer
| Head/Neck
| Eleah Stringer (MSc thesis)
| February 2021
|
Community Based Oral Caries Risk Pilot Study on Head and Neck Cancer Patients Treated with Radiation
| Head/Neck
| Dr. Pamela Gardner
|
September 2021
|
Late RAD: The Lived Experience of Late Radiation Associated Dysphagia
| Head/Neck
| Hilary Cochrane
| IN SET-UP
|
Orbital Adnexal Indolent Lymphoma: A retrospective study of the International Lymphoma Radiation Oncology Group (ILROG)
| Lymphoma
| Dr. Caroline Holloway
| IN SET-UP
|
Investigating the biochemical effects of intermittent fasting (IF) on CLL tumour control and autophagy induction by using a case-controlled study of CLL/SLL patients at BC Cancer - Victoria
| Leukemia/
Lymphoma
| Dr. Nicol Macpherson
| February 2021
|
Does Timing Matter? A case crossover study of intermittent fasting (IF) in patients with CLL/SLL at BC Cancer - Victoria
| Leukemia/
Lymphoma
| Dr. Nicol Macpherson
| IN SET-UP
|
Safety and Efficacy of Immunotherapy for Melanoma in Everyday Practice
| Melanoma
| Dr. Doran Ksienski
| January 2017
|
Real world efficacy and toxicity of immunotherapy for advanced non small cell lung cancer (NSCLC) amongst patients treated at BC Cancer
| NSCLC Lung
| Dr. Doran Ksienski
| August 2019
|
Pembrolizumab in Non-Small Cell Lung Cancer (NSCLC): Effects of time to treatment and discontinuation on survival
| NSCLC Lung
| Dr. Doran Ksienski
| IN SET-UP
|
DETERMINE: A retrospective study of archival NSCLC biopsy samples to investigate the value of the DetermalO gene expression assay in identifying immune checkpoint inhibitor responses
| NSCLC Lung
| Dr. David Saltman
| February 2021
|
NPGENCO: Evaluation of Nurse Practitioner Led Consenting Seminar for Genetic Testing using the GCOS-24 Scale
| Ovarian
| Laurie Barnhardt
| January 2021
|
iMETABO: Metabolic tracing of tumour and T cells in the ascites of ovarian cancer patients
| Ovarian
| Dr. Julian
Lum
| June 2021
|
Use of the BC Cancer Clinical Guided PERT Tool in the Identification and Management of Pancreatic Enzyme Insufficiency in Pancreatic Cancer
| Pancreas
| Dr. JP McGhie
| November 2020
|
PREVALENCE: Biomarker study to determine frequency of DNA-repair defects in men with metastatic prostate cancer
| Prostate
| Dr. Sunil Parimi
| December 2019
|
Adaptive Radiation Therapy: Improving treatment precision and clinical workflow with Machine Learning driven auto-contouring of prostate Cone-Beam CT imaging
| Prostate
| Dr. Abraham Alexander
|
April 2020
|
BC Prostate Ultrahypofractionation or Stereotactic Ablative Body Radiotherapy (SABR) Registry
| Prostate
| Dr. Abraham Alexander
| June 2021
|
Immunomodulatory effects of prostate brachytherapy and SBRT
|
Prostate
| Dr. Abraham Alexander
| May 2021
|
Treatment options for synchronous prostate and rectal cancer
| Prostate/Rectal
| Dr. Heloise Lavoie-Gagnon
| IN SET-UP
|
CanSaRCC BC Cancer: Clinical Outcome and Genetic Analysis of Sarcoma
| Sarcoma
| Dr. Xiaolan Feng
| July 2021
|
